CNS Pharmaceuticals, Inc.

Pharmaceuticals · HOUSTON, TX

PharmaceuticalsSEC Form D

CNS Pharmaceuticals, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 19, 2026, reporting $22,525,000 raised.

Incorporated in Nevada and based in HOUSTON, TX, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that CNS Pharmaceuticals, Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Rami LevinExecutive Officer · Director
  • Steve O'LoughlinExecutive Officer
  • Faith CharlesDirector
  • Michal FisherDirector
  • Jeffry KeyesDirector
  • Bettina CockroftDirector
  • Amy MaheryDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
$100.0KRaised

PharmassetX Inc.

PharmaceuticalsLOUISVILLE, KY
Apr 30, 2026View SEC Form D
CNS Pharmaceuticals, Inc. raised $22.5M — SEC Form D